Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Biocept Inc (NQ: BIOC )

1.130 +0.030 (+2.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 46,350
Open 1.110
Bid (Size) 1.090 (2)
Ask (Size) 1.180 (2)
Prev. Close 1.100
Today's Range 1.100 - 1.130
52wk Range 0.8000 - 28.50
Shares Outstanding 17,787,185
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases
From Biocept, Inc.
Via Business Wire
Crude Oil Moves Higher; Kroger Earnings Beat Estimates
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite edging higher on Friday. The Dow traded up 0.10% to 34,535.92 while the NASDAQ rose 0.02% to 13,751.67. The S&P... 
Via Benzinga
Topics Earnings Stocks
Exposures Financial Fossil Fuels US Equities

Performance

YTD
-93.15%
-93.15%
1 Month
+37.64%
+37.64%
3 Month
-8.13%
-8.13%
6 Month
-89.64%
-89.64%
1 Year
-95.94%
-95.94%

More News

Read More
Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Dow Gains 100 Points; US Wholesale Inventories Fall In July
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Mostly Higher; RH Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Cancer Diagnostic Focused Biocept Stock Trading Higher Today?
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics
From Biocept, Inc.
Via Business Wire
EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers
Via Benzinga
Biocept to Participate in the H.C. Wainwright Global Investment Conference
From Biocept, Inc.
Via Business Wire
Biocept to Hold Business Update Conference Call on August 30, 2023
From Biocept, Inc.
Via Business Wire
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
Via InvestorPlace
Biocept Reports Second Quarter 2023 Financial Results
From Biocept, Inc.
Via Business Wire
Biocept’s CNSide™ Cerebrospinal Fluid Assay Featured in Two Oral Presentations at the 2023 SNO/ASCO CNS Cancer Conference
From Biocept, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Biocept Announces the Passing of Board Chair M. Faye Wilson
From Biocept, Inc.
Via Business Wire
Biocept Names Antonino Morales as President and Chief Executive Officer
From Biocept, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Scientific Poster Presented at the 2023 ASCO Annual Meeting Highlights Performance of Biocept’s CNSide™ Versus Cytology
From Biocept, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.